News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

Fezolinetant eases symptoms in menopausal women unfit for hormone therapy
04 Dec 2024
byStephen Padilla
Use of fezolinetant demonstrates efficacy and good tolerability in the treatment of moderate-to-severe vasomotor symptoms associated with menopause in women who are deemed unsuitable for hormone therapy, reports a study.
04 Dec 2024

HCC risk higher in MASLD patients who smoke, drink alcohol
20 Nov 2024
Patients with metabolic dysfunction-associated steatotic liver disease (MASLD) are at greater risk of developing incident hepatocellular carcinoma (HCC) when factors such as smoking, alcohol use, obesity, diabetes, and hypertension are present, according to a study. However, use of statin, metformin, or aspirin may modify disease progression.
20 Nov 2024






